Stay updated with breaking news from Nasdaq Hoth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hoth Therapeutics (NASDAQ:HOTH – Get Rating) had its target price cut by EF Hutton Acquisition Co. I from $33.00 to $14.00 in a research note published on Monday morning, Benzinga reports. They currently have a buy rating on the stock. Hoth Therapeutics Trading Down 4.3 % Shares of Hoth Therapeutics stock opened at $1.99 on […]
Hoth Therapeutics, Inc. (NASDAQ:HOTH – Get Rating) was the recipient of a significant decline in short interest in May. As of May 31st, there was short interest totalling 58,500 shares, a decline of 81.2% from the May 15th total of 311,100 shares. Based on an average trading volume of 4,100,000 shares, the days-to-cover ratio is […]
Hoth Therapeutics (NASDAQ:HOTH – Get Rating) had its price target decreased by stock analysts at Benchmark to $4.00 in a research report issued to clients and investors on Friday, Stock Target Advisor reports. NASDAQ:HOTH traded up $0.02 during midday trading on Friday, hitting $0.45. 6,100 shares of the company traded hands, compared to its average […]
Hoth Therapeutics, Inc. (NASDAQ:HOTH – Get Rating) was the target of a significant increase in short interest in March. As of March 15th, there was short interest totalling 380,700 shares, an increase of 404.2% from the February 28th total of 75,500 shares. Based on an average daily volume of 5,290,000 shares, the short-interest ratio is […]